Alnylam Pharmaceuticals | Fremdkapital



Loan Capital Veränderung Datum
Acadia Pharmaceuticals USD 0 0 2024-12
Agios Pharmaceuticals USD 0 0 2024-12
Alnylam Pharmaceuticals USD 1.02B 967K 2024-12
Amgen USD 56.55B 305M 2024-12
Arrowhead Research USD 407.79M 14.61M 2024-12
BioMarin Pharmaceutical USD 595.89M 1.27M 2024-12
Incyte USD 33.54M 5.32M 2024-12
Ionis Pharmaceuticals USD 1.25B 11.67M 2024-12
Moderna USD 39M 586M 2024-12
Neurocrine Biosciences USD 0 0 2024-12
Novartis USD 22.93B 2.41B 2024-12
PTC Therapeutics USD 2.12B 179K 2024-12
Regeneron Pharmaceuticals USD 2.7B 720.4M 2024-12
Sanofi 11.79B 712M 2024-12
Sarepta Therapeutics USD 1.14B 1.16M 2024-12
Takeda JPY 4.7T 277.59B 2024-12
Tectonic Therapeutic USD 387K 126K 2024-12
Ultragenyx Pharmaceutical USD 0 0 2024-12
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12
Xencor USD 115.16M 104.99M 2024-12



Alnylam Pharmaceuticals Fremdkapital - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Apr 2025.